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ALLOGENEIC CHONDROPROGENITORS DISPLAY
IMMUNOSUPPRESSIVE PROPERTIES AND ARE NON-IMMUNOGENIC
IN VITRO
P. Lohan, O. Treacy, K. Lynch, M. Grifﬁn, T. Ritter, A.E. Ryan. Natl. Univ. of
Ireland, Galway, Galway, Ireland
Purpose: To investigate the interactions between allogeneic articular
chondroprogenitors and immune cells in vitro by comparing them to
allogeneic MSC
Methods: Primary articular chondroprogenitors were isolated from the
knees of Dark Agouti rats. These cells were used in co-culture systems
with allogeneic lymphocytes to determine the immune response eli-
cited by and immunosuppressive ability of the chondroprogenitors.
Speciﬁc inhibitors of signalling molecules were used to determine the
mechanism of chondroprogenitor immunosuppression. Flow cyto-
metric assays were used to assay the allogeneic T cell response to
chondroprogenitors. Chondroprogenitors ability to alter the polar-
isation of allogeneic macrophages was also investigated by ﬂow
cytometry, qPCR and zymography.
Results: We found that allogeneic chondroprogenitors elicit allogeneic
T cell proliferation similar to Mesenchymal Stem Cells (MSC), indicating
that these cells are weakly immunogenic. The chondroprogenitors were
not targeted any more than MSC by allo-speciﬁc cytotoxic T cells and
these cytotoxic T cells expressed low levels of the cytotoxic molecule
Granzyme-B. The immunogenicity of the chondroprogenitors was not
increased by exposure to an in vitro inﬂammatory environment.
Interestingly we found that allogeneic chondroprogenitors were capa-
ble of suppressing allogeneic T cell proliferation. This inhibition was not
dependent on cell contact, as is the case with MSC. We found that
chondroprogenitors suppress T cell proliferation by IL1b induced nitric
oxide production. Chondroprogenitors, like MSC, also produce sig-
niﬁcant amount of the immunosuppressive molecule PGE2.
Macrophages play an important role in OA, therefore we analysed the
effects of chondroprogenitors on macrophage polarisation. We found
that chondroprogenitors exert effects on the expression of cytokines
IL10 and IL12 in macrophages similar to allogeneic MSC. Additionally
similar MMP secretion was observed in chondroprogenitor/macro-
phage co-culture as MSC/macrophage co-culture.
Conclusions: These data indicate that allogeneic articular chon-
droprogenitors are weakly immunogenic, are capable of suppressing
allogeneic T cells and altering the polarisation of allogeneic macro-
phages. This raises the potential for use of allogeneic chon-
droprogenitors to treat cartilaginous defects in vivo. Such a treatment
would greatly reduce the costs of the procedure and indeed, due to the
fact that allogeneic chondroprogenitors produce immunosuppressive
molecules in an inﬂammatory environment, may be preferable to
autologous treatments as the allogeneic cells may ameliorate the
inﬂammatory component of diseases such as OA, while also repairing
the damaged tissue.
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EX VIVO TISSUE CULTURES OF BONE, CARTILAGE AND SYNOVIUM
WITH CORRESPONDING BIOMARKERS: A TOOL BOX FOR DRUG
DISCOVERY
C.S. Thudium, A.S. Siebuhr, C.F. Kjelgaard-Petersen, Y. He,
N.S. Gudmann, K. Henriksen, T. Christiansen, M.A. Karsdal,
A.C. Bay-Jensen. Nordic BioSci. A/S, Herlev, Denmark
Purpose: The joint consists of 3 major tissue compartments; articular
cartilage, synovium and subchondral bone. Each consists of a speciﬁc
extracellular matrix (ECM), which is remodeled as part of the patho-
genesis of osteoarthritis (OA). The tissues are believed to act as disease
drivers and thus may describe three different phenotypes in OA; car-
tilage-, bone- and synovial-driven OA. Development of potential drugs
for treatment is highly dependent on model systems of the different
compartments that can accurately describe the activity and mode of
action of the candidate drug. We have previously shown that cartilage
explant cultures as well as primary osteoclast cultures are viable tools
that in combination with biomarkers of ECM turnover can be used to
proﬁle potential disease modulating molecules. The aim of the study
was to develop and characterize ex vivo culture models of cartilage,bone and synovial turnover with speciﬁc biomarkers for each tissue
that would allow for testing of pathways and hypotheses. This includes
the development of a novel synovial membrane ex vivo model.
Methods: Synovial membrane explants (SME); Synovial membrane from
4 OA patients undergoing total knee replacement at Gentofte Hospital,
Denmark, were cultured as SMEs (30±2mg) for 3 weeks with media
alone (w/o), 10 ng/mL TNFa, IL-1b or TGFb-2, or metabolic inactivated.
Supernatant was collected 3 times a week and stored at -20C. In-house
neo-epitope biomarkers; C1M, C3M, and active MMP-3were assessed by
ELISA. MMP-2 and -9 were detected by gelatin zymography.
Bovine cartilage explants (BEX): Cartilage explants were harvested from
the femoral condyle of a cow and cultured as full depth cartilage (FDC)
explants for 3 weeks with media alone (w/o) or 20ng/ml TNFa plus
10ng/ml OSM (OþT). Biomarkers of degradation (AGNx1, C2M) and
formation (P2NP) were assessed in the supernatant by ELISA.
Human cartilage explants (HEX); Human articular cartilage from 4 OA
patients (see SME), were cultured as FDC explants for 3 weeks with
media alone (w/o) or OþT and biomarkers measured as described for
BEX.
Human osteoclasts (hOC); Mature human osteoclasts were derived
from peripheral blood monocytes and differentiated into mature
osteoclasts in culture medium containing 25 ng/ml M-CSF and 25 ng/ml
RANKL and seeded on bovine bone slices. Bone resorption was assessed
by CTX-I and modulated by inhibitors such the cysteine proteinase
inhibitor E64. Differences between groups were assessed by ANOVA.
Results: SME: C1M and C3M were increased at day 7 in response to
TNFa compared to w/o (10-fold for C1M p<0.05 and 100-fold for C3M:
p<0.0001). IL-1b showed similar pattern. TGFb-2 did not affect C1M or
C3M. Activated MMP-9 and activated MMP-3 (p<0.0001) was increased
in SMEs treated with IL-1b or TNFa throughout the study, while acti-
vation of MMP-2 was not affected.
BEX: The level of AGNx1 and C2M in BEX cultures increased sig-
niﬁcantly over 3 weeks treatment period with TNF-alpha (500-fold and
6-fold, respectively, p<0.001) compared to w/o. Furthermore, activated
ADAMTS-4, MMP-9 and MMP13 were increased at the later stages of
pro-inﬂammatory stimuli. All signals could be inhibited by speciﬁc
inhibitors of ADAMTS and MMP.
HEX: AGNx1 was signiﬁcantly increased at day 7 (p<0.0001) and 14
(p<0.01) in response to catabolic activation by OþT, while a trend
towards an increase was seen in C2M. No effects were observed on the
type II collagen formation marker P2NP.
HOC: The levels of the bone resorption marker CTX-I was signiﬁcantly
increased <1000% (P<0.001) in response to RANKL as previously
reported, and inhibited by bisphosphonates and cathepsin K inhibitors
as well acidiﬁcation inhibitors.
Conclusions: We have characterized 4 primary tissue models with
corresponding biomarkers of cartilage, bone and synovium. The toolbox
may provide a fast and early signal for the mode of action of novel drug
candidates.
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THE ROLE OF INFLAMMATORY MEDIATORS IN MENISCUS AND
CARTILAGE CROSSTALK IN OSTEOARTHRITIS
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